Atlas Trials

Evaluate the Efficacy and Safety of DWJ1506 and DWJ1507

Clinical trial NCT04772443 · UNKNOWN

Trial details

NCT number
NCT04772443
Sponsor
Daewoong Pharmaceutical Co. LTD.
Status
UNKNOWN
Phase
Phase 3
Study type
INTERVENTIONAL
Dyslipidemias
Start date
2021-02-01
Primary completion
2022-12-01
Enrollment
280

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.